St. Louis researchers receive recognition for groundbreaking Alzheimer’s diagnostic test
A blood test developed by the founders of C2N Diagnostics was the first of its kind to measure a key marker of Alzheimer's disease in patients.
www.stlpr.org
WashU Medicine Knight ADRC
